1.2800
27-نوفمبر-24 15:45:00
15 متأخرة بدقائق
الأسهم
-0.0100
-0.78%
نطاق اليوم
1.2400 - 1.3200
ISIN
N/A
المصدر
NASDAQ
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer
12 يونيو 2023 08:15:00 بحسب Nasdaq GlobeNewswire
Atossa Appoints Life Sciences Financial and Operations Industry Veteran Greg Weaver as Chief Financial Officer
01 يونيو 2023 08:10:00 بحسب Nasdaq GlobeNewswire